BioTarget 2019 finalists compete in a pitch finale held in London, UK
OXFORD, UK – 11 June 2019 Eight biotech companies from around the world were selected as finalists to compete for free experimentation worth $170,000 on the Arctoris robotic system. A distinguished panel – including Sonal Patel (VP, Oncology Lead, Johnson & Johnson), Jackie Hunter (CEO, BenevolentBio/ Director, Benevolent AI), Tony Hickson (CBO, Cancer Research UK), and Vishal Gulati (Deep Tech/ Health Tech VC Investor) – chose the three winners during the BioTarget 2019 pitch finale in Central Working White City (London, UK).
Congratulations to the 2019 winners: Arjuna Therapeutics, SpyCombinator and CDK11B.
BioTarget 2019, a non-profit biotech business competition, was was run in partnership by Arctoris, Insilico Medicine, Science Entrepreneur Club, and Clustermarket and attracted applications from all over the world.
About Arctoris Ltd
Arctoris Ltd is an Oxford-based research company that is revolutionising drug discovery for virtual and traditional biotechnology companies, pharmaceutical corporations and academia. Arctoris has established the world’s first fully automated drug discovery platform, offering pre-optimised and fully validated processes for its partners and customers globally. Accessible remotely, the platform provides on-demand access to a wide range of biochemical, cell biology and molecular biology assays conducted by robotics, enabling rapid, informed decision-making in basic biology, target validation, toxicology and phenotypic screening. These assay capabilities are accessed using a powerful online portal that streamlines experiment planning, ordering, tracking and data analysis. Thanks to the Arctoris platform, customers can rapidly, accurately and cost-effectively perform their research and advance their drug discovery programmes.
For media enquiries, please contact:
Head of Office
READY TO GET STARTED?
To find out how to accelerate your project timelines and generate higher quality data, reach out to us today.